Programa de Pós-Graduação em Biologia Parasitária na Amazônia, Universidade do Estado do Pará e Instituto Evandro Chagas, Tv. Perebebui, 2623, Belem 66087-662, Brazil.
Programa de Pós-Graduação em Epidemiologia e Vigilância em Saúde, Instituto Evandro Chagas, BR 316, km 7, Ananindeua 67000-000, Brazil.
Int J Environ Res Public Health. 2021 Feb 2;18(3):1335. doi: 10.3390/ijerph18031335.
Tuberculosis (TB) is an infectious communicable disease, which despite global efforts, still needs special attention in regions with difficult access. This study aims to describe the spatial and epidemiological trends of TB incidences from 2013 to 2018 in Marajó Island, the Amazonian region, Pará, Brazil. We have obtained secondary data from the Brazilian TB databases and performed geospatial and statistical analyses on the data for new TB cases, relapses, and re-admissions. From 2013 to 2018, 749 new cases were reported, in which the diagnostics (culture) was not performed for 652 (87.2%) patient samples, the drug resistance test (DST) was performed for nine (1.2%) samples, and one (0.13%) was multidrug-resistant TB (MDR-TB). The rapid molecular testing (RMT) was performed on 40 (5.3%) patient samples, with results indicating that eight (20%) were susceptible to rifampicin and two (5%) were rifampicin resistant. Overall, the cure rate was 449 (66.7%), while relapses and re-admissions were 41 and 44, respectively. On the geospatial distribution, the municipality of Soure stands out with a high number of incidences, relapses, and re-admissions. Spatially, the eight MDR cases were randomly distributed. Our data highlight the urgent need for TB control measures in this region, by introducing the Xpert-Ultra MTB/RIF (Cepheid, Sunnyvale, CA, USA) and Ogawa-Kudoh.
肺结核(TB)是一种传染性疾病,尽管全球都在努力,但在交通不便的地区仍需特别关注。本研究旨在描述 2013 年至 2018 年巴西帕拉州亚马逊地区马拉若岛肺结核发病率的空间和流行病学趋势。我们从巴西结核病数据库中获得了二手数据,并对新的肺结核病例、复发和再入院数据进行了地理空间和统计分析。2013 年至 2018 年,共报告了 749 例新发病例,其中 652 例(87.2%)患者样本未进行诊断(培养),9 例(1.2%)进行了耐药性测试(DST),1 例(0.13%)为耐多药结核病(MDR-TB)。对 40 例(5.3%)患者样本进行了快速分子检测(RMT),结果表明 8 例(20%)对利福平敏感,2 例(5%)对利福平耐药。总体治愈率为 449 例(66.7%),复发和再入院分别为 41 例和 44 例。在地理空间分布上,苏雷市的发病率、复发率和再入院率较高。从空间上看,8 例耐多药病例分布较为随机。我们的数据强调了在该地区急需采取结核病控制措施,引入 Xpert-Ultra MTB/RIF(Cepheid,Sunnyvale,CA,USA)和 Ogawa-Kudoh。